摘要: This invention relates to compounds that are useful in the treatment and prevention of seizures. In particular, reducing duration a seizure, susceptibility seizure onset, delaying onset and/or eliminating occurance patient. Examples include:(see formula I); (see II); III); or IV), any stereoisomer thereof.
google.co.in 参考文章(65)
Keisuke Kuida, Richard A. Flavell, Genetically altered mice deficient in functional caspase-9 ,(2000)
Hamish Allen, William Harter, Bruce Roth, Hans Albrecht, Catherine Kostlan, Kenneth Brady, Nigel Walker, Sulfonamide interleukin-1beta converting enzyme inhibitors ,(2001)
Paul Galatsis, Joseph Scott Warmus, Robert Vincent Talanian, Hamish John Allen, John Lodge Gilmore, Kenneth Dale Brady, Bradley William Caprathe, Nigel Walker, Sheryl Jeanne Hays, Hydroxamate inhibitors of interleukin-1β converting enzyme ,(1997)
Marion W. Wannamaker, Cornelia Forster, Process and intermediates for making substituted aspartic acid acetals ,(2001)
John C R Randle, Treatment of diseases using ICE inhibitors ,(2005)
Gordon B. Mills, Douglas R. Green, Eckard Weber, Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death ,(2000)
Andrea L. C. Robidoux, Stefania Leonardi, John Stibbard, Petra Dieterich, Siro Serafini, Asymmetric synthesis of piperazic acid and derivatives thereof ,(2001)
David J. Livingston, Keith P. Wilson, James P. Griffith, Eunice E. Kim, CRYSTAL STRUCTURE AND MUTANTS OF INTERLEUKIN-1β CONVERTING ENZYME ,(1995)
Julian M. C. Golec, Michael Mortimore, Caspase inhibitor prodrugs ,(2003)
Roland E. Dolle, Jasbir Singh, Gary Speier, Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors ,(1994)